RAFT-synthesized copolymers and conjugates designed for therapeutic delivery of siRNA

The advent of controlled radical polymerization (CRP) techniques, along with advancements in facile conjugation chemistry, now allow synthetic tailoring of precise, polymeric architectures necessary for drug/gene delivery. Reversible addition-fragmentation chain transfer (RAFT) polymerization and it...

Full description

Saved in:
Bibliographic Details
Published in:Polymer chemistry 2011-01, Vol.2 (7), p.1428-1441
Main Authors: Smith, DeeDee, Holley, Andrew C, McCormick, Charles L
Format: Article
Language:English
Subjects:
Architecture
Barriers
Conjugation
Genes
Polymerization
Rafts
Reagents
Ribonucleic acids
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The advent of controlled radical polymerization (CRP) techniques, along with advancements in facile conjugation chemistry, now allow synthetic tailoring of precise, polymeric architectures necessary for drug/gene delivery. Reversible addition-fragmentation chain transfer (RAFT) polymerization and its aqueous counterpart (aRAFT) afford quantitative control over key synthetic parameters including block length, microstructure, and placement of structo-pendent and structo-terminal functionality for conjugation of active agents and targeting moieties. The relevance of water-soluble and amphiphilic (co)polymers synthesized by RAFT for in vivo delivery of therapeutics in biological fluids is an especially attractive feature. In many cases, polymerization, binding, conjugation, and stimulus-induced release can be accomplished directly in aqueous media. This review focuses on RAFT synthesized (co)polymers as vectors for delivery of small interfering ribonucleic acid (siRNA) and gene down-regulation via the RNA interference (RNAi) pathway. Synthetic strategies utilizing RAFT and facile side- and end-chain reaction chemistries to afford modular delivery architectures (linear, stars/hyperbranched, micelles, and hybrid (co)polymeric vehicles) are reviewed based on examples from current literature. Also, specific problems, barriers, and challenges regarding rational design of polymeric delivery systems for therapeutic siRNA are presented.
ISSN:1759-9954
1759-9962
DOI:10.1039/C1PY00038A